George K Ng Processa Pharmaceuticals, Inc. (PCSA) insider trading activity

PCSA Quotes by TradingView

George K Ng is Chief Executive Officer of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 200,000 shares of PCSA, which is worth approximately $184,000. The most recent transaction as insider was on Oct 12, 2023, when has been sold 100,000 shares (Common Stock) at a price of $0.25 per share, resulting in proceeds of $25,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 200K
0% 3M change
0% 12M change
Total Value Held $184,000

George K Ng Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 12 2023
BUY
Grant, award, or other acquisition
$25,000 $0.25 p/Share
100,000 Added 33.33%
200,000 Common Stock
Oct 10 2023
BUY
Grant, award, or other acquisition
$25,000 $0.25 p/Share
100,000 Added 50.0%
100,000 Common Stock

Also insider at

KTRA
Kintara Therapeutics, Inc. Healthcare
GKN

George K Ng

Chief Executive Officer
Hanover, MD

Track Institutional and Insider Activities on PCSA

Follow Processa Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

News

Receive news related to Processa Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCSA